Literature DB >> 1527987

Persistent hypermethioninaemia with dominant inheritance.

H J Blom1, A J Davidson, J D Finkelstein, A S Luder, I Bernardini, J J Martin, A Tangerman, J M Trijbels, S H Mudd, S I Goodman.   

Abstract

A clinically benign form of persistent hypermethioninaemia with probable dominant inheritance was demonstrated in three generations of one family. Plasma methionine concentrations were between 87 and 475 mumol/L (normal mean 26 mumol/L; range 10-40 mumol/L); urinary methionine and homocystine concentrations were normal. Plasma homocystine, cystathionine, cystine and tyrosine were virtually normal. The concentrations in serum and urine of metabolites formed by the methionine transamination pathway were normal or moderately elevated. Methionine loading of two affected family members revealed a diminished ability to catabolize methionine, but the activities of methionine adenosyltransferase and cystathionine beta-synthase were not decreased in fibroblasts from four affected family members. Fibroblast methylenetetrahydrofolate reductase activity and its inhibition by S-adenosylmethionine were also normal, indicating normal regulation of N5-methyltetrahydrofolate-dependent homocysteine remethylation. Serum folate concentrations were not increased. The findings in this family differ from those previously described for known defects of methionine degradation. Since the hepatic and fibroblast isoenzymes of methionine adenosyltransferase differ in their genetic control, this family's biochemical findings appear consistent with a mutation in the structural gene for the hepatic methionine adenosyltransferase isoenzyme.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1527987     DOI: 10.1007/bf01799629

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  28 in total

Review 1.  Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy.

Authors:  P M Ueland; H Refsum
Journal:  J Lab Clin Med       Date:  1989-11

2.  Abnormal methionine adenosyltransferase in hypermethioninemia.

Authors:  J D Finkelstein; W E Kyle; J J Martin
Journal:  Biochem Biophys Res Commun       Date:  1975-10-27       Impact factor: 3.575

3.  Methionine metabolism in mammals. Adaptation to methionine excess.

Authors:  J D Finkelstein; J J Martin
Journal:  J Biol Chem       Date:  1986-02-05       Impact factor: 5.157

4.  Transsulfuration in mammals. Microassays and tissue distributions of three enzymes of the pathway.

Authors:  S H Mudd; J D Finkelstein; F Irreverre; L Laster
Journal:  J Biol Chem       Date:  1965-11       Impact factor: 5.157

5.  Deranged B 12 metabolism: studies of fibroblasts grown in tissue culture.

Authors:  S H Mudd; B W Uhlendorf; K R Hinds
Journal:  Biochem Med       Date:  1970-11

6.  Feedback inhibition of methylene-tetrahydrofolate reductase in rat liver by S-adenosylmethionine.

Authors:  C Kutzbach; E L Stokstad
Journal:  Biochim Biophys Acta       Date:  1967-05-16

7.  Transamination of methionine in humans.

Authors:  H J Blom; G H Boers; J P van den Elzen; W A Gahl; A Tangerman
Journal:  Clin Sci (Lond)       Date:  1989-01       Impact factor: 6.124

8.  The natural history of homocystinuria due to cystathionine beta-synthase deficiency.

Authors:  S H Mudd; F Skovby; H L Levy; K D Pettigrew; B Wilcken; R E Pyeritz; G Andria; G H Boers; I L Bromberg; R Cerone
Journal:  Am J Hum Genet       Date:  1985-01       Impact factor: 11.025

9.  Differences between premenopausal women and young men in the transamination pathway of methionine catabolism, and the protection against vascular disease.

Authors:  H J Blom; G H Boers; J P van den Elzen; J J van Roessel; J M Trijbels; A Tangerman
Journal:  Eur J Clin Invest       Date:  1988-12       Impact factor: 4.686

10.  Hypermethioninemia associated with methionine adenosyltransferase deficiency: clinical, morphologic, and biochemical observations on four patients.

Authors:  G E Gaull; H H Tallan; D Lonsdale; H Przyrembel; F Schaffner; D B von Bassewitz
Journal:  J Pediatr       Date:  1981-05       Impact factor: 4.406

View more
  7 in total

1.  Dominant inheritance of isolated hypermethioninemia is associated with a mutation in the human methionine adenosyltransferase 1A gene.

Authors:  M E Chamberlin; T Ubagai; S H Mudd; H L Levy; J Y Chou
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

2.  Methionine adenosyltransferase I/III deficiency: novel mutations and clinical variations.

Authors:  M E Chamberlin; T Ubagai; S H Mudd; J Thomas; V Y Pao; T K Nguyen; H L Levy; C Greene; C Freehauf; J Y Chou
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

3.  Maternal methionine adenosyltransferase I/III deficiency: reproductive outcomes in a woman with four pregnancies.

Authors:  S H Mudd; A Tangerman; S P Stabler; R H Allen; C Wagner; S H Zeisel; H L Levy
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

4.  Isolated persistent hypermethioninemia.

Authors:  S H Mudd; H L Levy; A Tangerman; C Boujet; N Buist; A Davidson-Mundt; L Hudgins; K Oyanagi; M Nagao; W G Wilson
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

5.  Hypermethioninaemia due to methionine adenosyltransferase I/III (MAT I/III) deficiency: diagnosis in an expanded neonatal screening programme.

Authors:  M L Couce; M D Bóveda; D E Castiñeiras; F J Corrales; M I Mora; J M Fraga; S H Mudd
Journal:  J Inherit Metab Dis       Date:  2008-05-20       Impact factor: 4.982

6.  Adenosine kinase deficiency: expanding the clinical spectrum and evaluating therapeutic options.

Authors:  Christian Staufner; Martin Lindner; Carlo Dionisi-Vici; Peter Freisinger; Dries Dobbelaere; Claire Douillard; Nawal Makhseed; Beate K Straub; Kimia Kahrizi; Diana Ballhausen; Giancarlo la Marca; Stefan Kölker; Dorothea Haas; Georg F Hoffmann; Sarah C Grünert; Henk J Blom
Journal:  J Inherit Metab Dis       Date:  2015-12-07       Impact factor: 4.982

7.  Confirmation that MAT1A p.Ala259Val mutation causes autosomal dominant hypermethioninemia.

Authors:  Michael J Muriello; Sarah Viall; Teodoro Bottiglieri; Kristina Cusmano-Ozog; Carlos R Ferreira
Journal:  Mol Genet Metab Rep       Date:  2017-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.